Abstract. Reproductive mortality includes mortality attributable to pregnancy, termination of pregnancy, childbirth and its sequelae, and contraception. Reproductive mortality has been estimated for the United Kingdom, the United States, and for states of the US. However, it has not previously been measured for developing countries, where maternal mortality often remains distressingly high.
Introduction
Reproductive mortality includes mortality attributable to pregnancy, termination of pregnancy, childbirth and its sequelae, and contraception.' Maternal mortality remains at distressingly high levels in Third World countries. Deaths due to pregnancy, abortion, and childbirth are likely to decline only if there is a marked improvement in obstetric care coupled with widespread adoption of family planning. Contraception reduces maternal mortality by reducing the number of pregnancies, especially those to women in high-risk groups, i.e., older women and women with many births. At the same time, contraception itself also carries a small but measurable risk. In developed countries, as mortality due to childbirth has decreased, deaths due to fertility control have become relatively more important. [1] [2] [3] The majority of the world's women are in developing countries where data on reproductive mortality are seriously lacking. This study was undertaken to determine in two developing countries the causes of death to women of reproductive age, the level ofreproductive mortality, and the proportion of reproductive deaths due to pregnancy/delivery and to contraception.
Methods
Two sites were selected for the study: the province of Bali in Indonesia, and the governorate of Menoufia in Egypt. These sites were chosen for: 1) prevalence of contraception; 2) an expected number of deaths sufficient for analysis; and 3) the likelihood of locating a high proportion of deaths. Because of the smaller population and lower death rate in Egypt, the study ran there for three years (January 1, 1981 to December 31, 1983 ). Locating Deaths Deaths occurring to women of reproductive age were identified from lists of all deaths. Lists of deaths were obtained in different ways for the two sites.
(2.2 per cent of this was attributable to contraception), and one province of Indonesia, where reproductive mortality was 70 per 100,000 (of which 1.4 per cent was due to contraception). In both locations, complications of pregnancy and childbirth were a leading cause of death in the age group studied (the first cause in Indonesia, second in Egypt). Contraceptive prevalence was 24 per cent of married women ages 15- or a part of a town. The field workers were asked to list all deaths in their villages during the previous month; they did this in consultation with village heads who keep records of births and deaths within their area. To estimate the proportion of deaths identified, we compared the age-specific death rates we found with those from a study using a different method of death identification.5 We estimate that we were able to locate between 45 per cent and 50 per cent of the deaths. Estimates of rates are, therefore, adjusted for undercount, and these rates are consistent with a life expectancy at birth of57.5 years that has been estimated for Bali and East Java.6 Although difficult to quantify, the most likely biases resulting from this serious undercount are: 1) women who use family planning are overrepresented, since family planning workers are more familiar with family planning acceptors and would be more likely to be aware of their deaths; 2) deaths in remote areas are underrepresented, since family planning workers are less likely to make regular visits to those areas. No data are available to test these two theories. However, only 26 per cent of women were using contraception at the time of death (34 per cent of the deaths unrelated to pregnancy) compared with 48 per cent for all women in Bali. We found no difference between older and younger women in the probability that the death would be reported. Deaths occurring in hospital were reported by the hospital. Thus, even though the field workers in the villages where the deceased lived only reported between 45 per cent and 50 per cent of the hospital deaths, the study was able to include all deaths from the complete lists provided by the hospital.
Data CoUlection
Trained interviewers visited the surviving family members and administered a standardized, pretested questionnaire on sociodemographic factors, symptoms of the disease that led to death, and reproductive and contraceptive history. The husband was interviewed in 78 per cent of the cases in Bali and in half the cases in Menoufia; the mother or mother-in-law was interviewed in 46 per cent of cases in Menoufia. AJPH Menoufia-In Menoufia, a panel of physicians met regularly to discuss cases. In most cases the diagnosis was made by a single physician, although questionable cases were discussed by the panel. The panel consisted of a pathologist, an obstetrician-gynecologist, an internist, and specialists in infectious diseases and public health; all were from the governorate in which the study was conducted. To assess the reliability ofthe diagnoses in the Egyptian study, a 10 per cent random sample of first-year data was rediagnosed during the second year by the panel. Of the 70 cases reexamined, 39 had an identical diagnosis, and 23 were in the same broad disease category. Among the eight cases with disagreement were four in which there was a reordering of the underlying and contributing causes. The most important result was a small increase in the percentage of deaths attributed to disease of the circulatory system, from 33 per cent to 36 per cent. The most stable categories, as expected, were trauma, malignancy, and pregnancy-related deaths.
The person making the diagnosis of the cause of death was intended to be unaware of the contraceptive practice of the deceased, but blinding procedures were not always followed in the first year of the study. For this reason, all women identified as using contraception at the time of death were rediagnosed at the same time as the random sample described above. For these 44 rediagnosed cases, 32 had an identical diagnosis, and seven remained in the same broad disease category. In the second and third years, the blindness procedures were correctly followed.
Bali-In Bali a majority of cases were diagnosed by one physician, a pathologist, with access to a panel of local physicians (specialists in internal medicine, obstetrics and gynecology, and public health) for more difficult cases. In Bali, the degree of consistency when cases were rediagnosed was greater, but the reasons for discrepancy were very similar. It should be noted, however, that consistency does not imply accuracy.
Assignment to one of 10 broad categories of disease (such as disease of the circulatory system) was generally straightforward, even if the precise cause (such as ischemic heart disease) could not be determined with certainty. A cause of death could not be assigned in 5.1 per cent of cases in Menoufia and in 7.8 per cent of cases in Bali. It is important to note that a relatively large proportion of deaths occurring at the reproductive ages are due to acute conditions (such as trauma, infection, pregnancy complications) without contributing conditions. This greatly facilitates assignment of a cause of death, because acute conditions are more easily diagnosed than the multiple, chronic conditions from which older people often die. In the absence of autopsy data, it is difficult to validate this method of diagnosing cause of death. In Bali, information from the attending physician was incorporated into the diagnosis; in Menoufia, this was not available. We are currently comparing our data from Menoufia with the cause of death on the death certificates; our data appear to be the more accurate.
The cause of death was coded using a modification of the ICD-9 Basic Tabulation List.
A troublesome aspect of this study is the absence of other data to support or refute our methodology or our findings. Death registration in Egypt has been found to be complete,4 but there are no available data on cause other than Reproductive mortality in Menoufia in 1981-83 was 46 per 100,000 women ages 15-49, ofwhich only 2.2 per cent was attributed to contraception. In Bali in 1980-82, reproductive mortality was 70 per 100,000 women, of which 1.4 per cent was due to contraception (Table 2) .
In Menoufia, reproductive mortality rates were similar for older and younger women. But in Bali, due to their lower fertility rates, older women had a reproductive mortality rate 28 per cent lower than younger women. In England, Wales, and the United States, older women have a reproductive mortality rate twice that of younger women, and more than three-fourths of their rate is due to oral contraception.'-3 In both Menoufia and Bali, on the other hand, reproductive mortality is dominated by maternal deaths. Deaths related to contraceptive use were rare and found only among women over age 30 (Table 2 ). In Menoufia, contraceptive-related deaths over the three years of the study are estimated at 9 in 68,583 users ofcontraception, or 4 per 100,000 users per year. All of these deaths were associated with oral contraception. (10), we attributed nine of the 19 deaths from heart disease in pill users to the use of the pills (see Table 3 ).
Few women who died in Bali had been oral contraceptive users (only 15 per cent of all family planning users choose this method); only one death due to cardiovascular disease occurred among users of oral contraception. (A 37-year-old hypertensive woman who died from a stroke had been taking oral contraceptives for several years even though another method had been recommended by clinic personnel.) Although we find the same two-fold risk of death from cardiovascular disease among pill users that we found in Menoufia, the confidence limits are wide and include unity.
Epidemiologic studies in the West have found an increased risk of ectopic pregnancy9 and pelvic inflammatory disease (PID)'1112 associated with intrauterine device (IUD) use. Both of these conditions can be difficult to diagnose. We found three cases of ectopic pregnancy in Menoufia, none of them in IUD users, and no cases in Bali (Table 4) . Because of the difficulty in diagnosis, we looked also at women dying with acute abdomen of unknown origin. In Menoufia none of the women dying with this symptom had been IUD users, but Table. "Hypertensive disease, ischemic heart disease, acute myocardial infarction, cerebrovascular disease, thromboembolism. ***Rheumatic heart disease, cardiopulmonary disorders and all other heart and drculatory disorders are included in this category. When these conditions are included in the cardiovascular category the odds ratio is 1.0 (0.6, 1.6); when excluded from both categories the odds ratio is 1. 9 (1.1, 3.4) . Table. in Bali six out of 19 were IUD users, giving a slightly increased risk of acute abdomen among users (odds ratio = 1.2, 95 per cent confidence limits are 0.5, 3.3). Examination of these six cases suggested that in two the possibility of ectopic pregnancy could not be ruled out. We found no cases of PID in current IUD users in either site (Table 4 ), but one of the two women in Bali diagnosed as having died from PID had recently had an IUD removed.
Thus in Bali, the deaths possibly related to contraceptives are one death from stroke to a woman using oral contraception, one death from infection soon after removal of an IUD, and two possible ectopic pregnancies in women with IUDs. (These two ectopics are not shown in Table 4 The most important finding to emerge from this study which remains firm in spite of methodologic shortcomings is that reproductive mortality is high in these two sites, and that almost all reproductive deaths are due to pregnancy and childbirth rather than contraception. also smoke.'5 There were no cardiovascular deaths to pill users under age 30 in either site in this study. These findings are consistent with the research findings from the United States and the United Kingdom.
In 1981, there were 309 maternal deaths in the United States (with a population of 220 million). This research reports 128 deaths per year in Menoufia with its population of only 1.9 million, and 279 deaths per year in Bali, which has a population of 2.6 million. These figures mean that, relative to their population size, Menoufia has 48 times as many maternal deaths and Bali 77 times as many as the United States. It is clear that the potential exists for great strides in reducing reproductive mortality in these two developing countries and that reducing fertility through contraception will make a significant contribution to that reduction.
